Pollen-specific allergen immunotherapy: is it safe to initiate the build-up phase during the pollen season? Or is needed to reduce the dose?

被引：0
|
作者：
Gonzalez-Martin, I [1 ]
De Luque-Pinana, V [1 ]
Eguez-Hidalgo, F. [1 ]
Rubiano-Sosa, C. [1 ]
Guardia-Martinez, P. [1 ]
机构：
[1] Virgen Macarena Univ Hosp, Seville, Spain
来源：
ALLERGY | 2012年 / 67卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
578
引用
收藏
页码：234 / 234
页数：1
相关论文
共 50 条
  • [1] Specific Immunotherapy, even during the Pollen Season, safe and contractual
    不详
    ALLERGO JOURNAL, 2021, 30 (03) : 76 - 76
  • [2] Specific Immunotherapy with a Polymerized Tree Pollen Allergen Extract is Effective and Safe
    Koehlmoos, C.
    Brehmer, D.
    Hippke, E.
    Hoelscher, U.
    Lemke, J.
    Neuhaus, M.
    Sieber, W.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2009, 123 (02) : S61 - S61
  • [3] Safety of an Accelerated Build-up Phase With Pollen Allergoids: A Retrospective Study
    Caruso, C.
    Borgonovo, L.
    Brame, B.
    Cocconcelli, A.
    Colantuono, S.
    Piantanida, M.
    Scarpa, S.
    Zisa, G.
    Romano, A.
    JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY, 2018, 28 (04) : 283 - 284
  • [4] Safety of 2 Build-up Cluster Immunotherapy Schedules With a High-Dose Hypoallergenic Pollen Therapeutic Extract
    Gonzalez-Gutierrez, M. L.
    Dominguez-Ortega, J.
    Torres-Hernandez, J. A.
    De-Luque-Pinana, V.
    Izquierdo-Calderon, J. P.
    Hernandez-Pena, J.
    JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY, 2013, 23 (03) : 201 - 203
  • [5] Safety of a shortened build-up phase in sublingual allergen specific immunotherapy. A multicenter, retrospective study
    Ferrara, A.
    Agostinis, F.
    Barra, R.
    Piunti, E.
    ALLERGY, 2010, 65 : 261 - 261
  • [6] Linear Epitope Binding Patterns of Grass Pollen-Specific Antibodies in Allergy and in Response to Allergen-Specific Immunotherapy
    Thornqvist, Linnea
    Sjoberg, Ronald
    Greiff, Lennart
    van Hage, Marianne
    Ohlin, Mats
    FRONTIERS IN ALLERGY, 2022, 3
  • [7] Mutants of the major ryegrass pollen allergen, Lol p 5, with reduced IgE-binding capacity: candidates for grass pollen-specific immunotherapy
    Swoboda, I
    De Weerd, N
    Bhalla, PL
    Niederberger, V
    Sperr, WR
    Valent, P
    Kahlert, H
    Fiebig, H
    Verdino, P
    Keller, W
    Ebner, C
    Spitzauer, S
    Valenta, R
    Singh, MB
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2002, 32 (01) : 270 - 280
  • [8] Adherence to Allergen Subcutaneous Immunotherapy is Increased by a Shortened Build-Up Phase: A Retrospective Study
    Caruso, Cristiano
    Brame, Barbara
    Bagnasco, Diego
    Cocconcelli, Alessia
    Ortolani, Valeria
    Pravettoni, Valerio
    Scarpa, Sergio
    Zisa, Giuliana
    Passalacqua, Giovanni
    Colantuono, Stefania
    BIOMED RESEARCH INTERNATIONAL, 2020, 2020
  • [9] Pollen-specific immunoglobulin E positivity is associated with worsening of depression scores in bipolar disorder patients during high pollen season
    Manalai, Partam
    Hamilton, Robert G.
    Langenberg, Patricia
    Kosisky, Susan E.
    Lapidus, Manana
    Sleemi, Aamar
    Scrandis, Debra
    Cabassa, Johanna A.
    Rogers, Christine A.
    Regenold, William T.
    Dickerson, Faith
    Vittone, Bernard J.
    Guzman, Alvaro
    Balis, Theodora
    Tonelli, Leonardo H.
    Postolache, Teodor T.
    BIPOLAR DISORDERS, 2012, 14 (01) : 90 - 98
  • [10] Allergen immunotherapy is safe during pollen season. Results of a 10-year, real-life prospective study
    Pitsios, C.
    Lefoussis, C.
    Dimitriou, A.
    Giannakopoulos, D.
    Ergazakis, M.
    Vartholomaios, S.
    Kouri, M.
    Larenas-Linnemann, D.
    Kompoti, E.
    REVUE FRANCAISE D ALLERGOLOGIE, 2017, 57 (04): : 302 - 307
12345